Introduction: Despite recent advances in microsurgical techniques, meningiomas involving the cavernous sinus remain a therapeutic challenge. Stereotactic fractionated radiotherapy (SRT) is now playing an important role in the management of such lesions either as a primary treatment or to control residual or recurrent tumors after previous surgery. Material and Methods: Between 1997 and 2003, 104 patients were treated with microsurgical resection and/or with SRT. We examined retrospectively the quality of life, outcome, and toxicity. Quality of life was evaluated by the medical outcome study Short Form-36 (SF-36). Responses of patients were divided into eight domains: physical functioning, physical role functioning, bodily pain, general health, vitality, social functioning, emotional role functioning, and mental health. Results: The median follow-up was 24 months. Eighty-four patients were female, 20 were male, the median age was 56 years (range: 31-79 yrs). The overall survival for 5 years was 92.9% and the progression-free survival for 5 years was 96.9%. No follow-up data were available for 8 patients. Ninety-six patients were selected in three therapeutic categories: primary microsurgery (22 patients), primary SRT (34 patients), and resection plus SRT (40 patients). Although no statistically significant differences between the three categories were observed, a tendency for primary SRT was seen, due to the quality of life. After microsurgical resection 47% of the patients developed temporary cranial nerve palsies and 19% of these became permanent. After SRT, 49% of patients developed temporary headache, vertigo, and nausea, and 13.2% of these became permanent. Conclusions: SRT offers an additional treatment option of high efficacy and excellent post-treatment quality of life with low risk and side effects. An interdisciplinary decision is necessary for each patient.